JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB18056

Anti-HEF1/NEDD-9 抗体 [2G9]

Anti-HEF1/NEDD-9 antibody [2G9]

5

(9 Reviews)

|

(35 Publications)

Mouse Monoclonal HEF1/NEDD-9 antibody. Suitable for ICC, IP, Flow Cyt, WB, IHC-P, ICC/IF, IHC-Fr and reacts with Human, Mouse, Rat samples. Cited in 35 publications. Immunogen corresponding to Synthetic Peptide within Human NEDD9 aa 50-400.

別名を表示する

CASL, NEDD9, Enhancer of filamentation 1, hEF1, CRK-associated substrate-related protein, Cas scaffolding protein family member 2, Neural precursor cell expressed developmentally down-regulated protein 9, Renal carcinoma antigen NY-REN-12, p105, CAS-L, CasL, CASS2, NEDD-9

8 Images
Immunocytochemistry/ Immunofluorescence - Anti-HEF1/NEDD-9 antibody [2G9] (AB18056)
  • ICC/IF

Lab

Immunocytochemistry/ Immunofluorescence - Anti-HEF1/NEDD-9 antibody [2G9] (AB18056)

Immunofluorescence staining of MDA-MB231 cells with the 2G9 antibody at a 1/200 dilution. Cells were fixed in 3.8% PFA for 10 minutes, and staining was performed for 1 hour at room temperature.

Immunocytochemistry - Anti-HEF1/NEDD-9 antibody [2G9] (AB18056)
  • ICC

Lab

Immunocytochemistry - Anti-HEF1/NEDD-9 antibody [2G9] (AB18056)

ICC/IF image of ab18056 stained MCF7 (human breast adenocarcinoma cell line) cells. The cells were fixed in 4% formaldehyde for 10 minutes and then incubated in 1%BSA / 10% normal goat serum / 0.3M glycine in 0.1% PBS-Tween for 1 hour to permeabilize the cells and block non-specific protein-protein interactions. The cells were then incubated with the antibody (ab18056, 1 μg/ml) overnight at +4°C. The secondary antibody (green) was Alexa Fluor® 488 goat anti-mouse IgG (H+L) used at a 1/1000 dilution for 1 hour. Alexa Fluor® 594 WGA was used to label plasma membranes (red) at a 1/200 dilution for 1 hour. DAPI was used to stain the cell nuclei (blue) at a concentration of 1.43 μM.

Immunocytochemistry/ Immunofluorescence - Anti-HEF1/NEDD-9 antibody [2G9] (AB18056)
  • ICC/IF

Lab

Immunocytochemistry/ Immunofluorescence - Anti-HEF1/NEDD-9 antibody [2G9] (AB18056)

Immunofluorescence analysis of paraformaldehyde fixed MCF7 cells, permeabilized with 0.15% Triton.

Primary incubation 1hr (1 : 100 dilution) followed by Alexa Fluor® 488 secondary antibody (1 : 1000 dilution), showing cytoplasmic staining. The nuclear stain is DAPI (blue).

Negative control : Mouse IgG1 negative control followed by Alexa Fluor® 488 secondary antibody.

Flow Cytometry - Anti-HEF1/NEDD-9 antibody [2G9] (AB18056)
  • Flow Cyt

Unknown

Flow Cytometry - Anti-HEF1/NEDD-9 antibody [2G9] (AB18056)

Overlay histogram showing A549 (human lung carcinoma cell line) cells stained with ab18056 (red line). The cells were fixed with 80% methanol (5 minutes) and then permeabilized with 0.1% PBS-Tween for 20 minutes. The cells were then incubated in 1x PBS / 10% normal goat serum / 0.3M glycine to block non-specific protein-protein interactions followed by the antibody (ab18056, 1 μg/ 1 x 106 cells) for 30 minutes at 22°C. The secondary antibody used was DyLight® 488 goat anti-mouse IgG (H+L) (ab96879) at 1/500 dilution for 30 minutes at 22°C. Isotype control antibody (black line) was mouse IgG1 [ICIGG1] (ab91353, 2 μg/ 1 x 106 cells) used under the same conditions. Acquisition of >5,000 events was performed. This antibody gave a positive signal in A549 cells fixed with 4% paraformaldehyde (10 minutes)/permeabilized in 0.1% PBS-Tween used under the same conditions.

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-HEF1/NEDD-9 antibody [2G9] (AB18056)
  • IHC-P

Unknown

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-HEF1/NEDD-9 antibody [2G9] (AB18056)

IHC image of ab18056 staining in human kidney formalin fixed paraffin embedded tissue section, performed on a Leica BondTM system using the standard protocol F. The section was pre-treated using heat mediated antigen retrieval with sodium citrate buffer (pH 6, epitope retrieval solution 1) for 20 minutes. The section was then incubated with ab18056, 10 μg/ml, for 15 minutes at room temperature and detected using an HRP conjugated compact polymer system. DAB was used as the chromogen. The section was then counterstained with haematoxylin and mounted with DPX.

For other IHC staining systems (automated and non-automated) customers should optimize variable parameters such as antigen retrieval conditions, primary antibody concentration and antibody incubation times.

Immunocytochemistry/ Immunofluorescence - Anti-HEF1/NEDD-9 antibody [2G9] (AB18056)
  • ICC/IF

Lab

Immunocytochemistry/ Immunofluorescence - Anti-HEF1/NEDD-9 antibody [2G9] (AB18056)

Immunofluorescence analysis of paraformaldehyde fixed MCF7 cells, permeabilized with 0.15% Triton.

Primary incubation 1hr (1 : 100 dilution) followed by Alexa Fluor® 488 secondary antibody (1 : 1000 dilution), showing cytoplasmic staining. The nuclear stain is DAPI (blue).

Negative control : Mouse IgG1 negative control followed by Alexa Fluor® 488 secondary antibody.

Western blot - Anti-HEF1/NEDD-9 antibody [2G9] (AB18056)
  • WB

Lab

Western blot - Anti-HEF1/NEDD-9 antibody [2G9] (AB18056)

Western blot : Anti-HEF1/NEDD-9 antibody [2G9] ab18056 staining at 0.1 µg/mL, shown in green; Rabbit anti alpha Tubulin (ab52866) loading control staining at 1/20,000 dilution, shown in magenta. A band was observed at 100 kDa in Wild-type A549 cell lysates with no signal observed at this size in NEDD9 knockout A549 cell line.

To generate this image, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 3pc Milk in TBS-0.1 % Tween® 20 (TBS-T) before incubation with primary antibodies overnight at 4 °C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged. Secondary antibodies used were Goat anti-Mouse 800CW & Goat anti-Rabbit 680RD at 1/20,000 dilution.

All lanes:

Western blot - Anti-HEF1/NEDD-9 antibody [2G9] (ab18056) at 0.1 µg/mL

Lane 1:

Wild-type A549 at 20 µg

Lane 2:

NEDD9 knockout A549 at 20 µg

Lane 3:

HepG2 at 20 µg

Lane 4:

PANC-1 at 20 µg

Secondary

All lanes:

Goat anti-Mouse 800CW & Goat anti-Rabbit 680RD at 1/20000 dilution

Predicted band size: 93 kDa

Observed band size: 100 kDa

false

Western blot - Anti-HEF1/NEDD-9 antibody [2G9] (AB18056)
  • WB

Lab

Western blot - Anti-HEF1/NEDD-9 antibody [2G9] (AB18056)

(0.1µg/ml) staining in MCF7 cells lysate (35µg protein in RIPA buffer). Primary incubation was 1 hour. Detected by chemiluminescence.

All lanes:

Western blot - Anti-HEF1/NEDD-9 antibody [2G9] (ab18056) at 0.1 µg/mL

Predicted band size: 92 kDa

false

Key facts

宿主種

Mouse

クローン性

Monoclonal

クローン番号

2G9

アイソタイプ

IgG1

軽鎖のタイプ

kappa

キャリアフリー

No

交差種

Human, Rat, Mouse

アプリケーション

Flow Cyt, ICC/IF, IHC-Fr, WB, IP, IHC-P, ICC

applications

免疫原

Synthetic Peptide within Human NEDD9 aa 50-400. The exact immunogen used to generate this antibody is proprietary information.

Q14511

特異性

Not tested on Sin1. This antibody mostly detects HEF1 / NEDD-9 localized at the focal adhesion sites.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "ICC" : {"fullname" : "Immunocytochemistry", "shortname":"ICC"}, "IP" : {"fullname" : "Immunoprecipitation", "shortname":"IP"}, "FlowCyt" : {"fullname" : "Flow Cytometry", "shortname":"Flow Cyt"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"}, "IHCFr" : {"fullname" : "Immunohistochemistry (Frozen sections)", "shortname":"IHC-Fr"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "ICC-species-checked": "testedAndGuaranteed", "ICC-species-dilution-info": "", "ICC-species-notes": "<p></p>", "IP-species-checked": "guaranteed", "IP-species-dilution-info": "", "IP-species-notes": "<p></p>", "FlowCyt-species-checked": "testedAndGuaranteed", "FlowCyt-species-dilution-info": "1 µg for 10^6 Cells", "FlowCyt-species-notes": "<p><a href='/products/primary-antibodies/mouse-igg1-kappa-monoclonal-15-6e10a7-isotype-control-ab170190'>ab170190</a> - Mouse monoclonal IgG1, is suitable for use as an isotype control with this antibody.</p>", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "0.1 µg/mL", "WB-species-notes": "<p></p>", "IHCP-species-checked": "testedAndGuaranteed", "IHCP-species-dilution-info": "", "IHCP-species-notes": "<p></p>", "ICCIF-species-checked": "guaranteed", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "<p></p>", "IHCFr-species-checked": "guaranteed", "IHCFr-species-dilution-info": "", "IHCFr-species-notes": "<p></p>" }, "Mouse": { "ICC-species-checked": "guaranteed", "ICC-species-dilution-info": "", "ICC-species-notes": "", "IP-species-checked": "guaranteed", "IP-species-dilution-info": "", "IP-species-notes": "<p></p>", "FlowCyt-species-checked": "guaranteed", "FlowCyt-species-dilution-info": "", "FlowCyt-species-notes": "", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "", "WB-species-notes": "<p></p>", "IHCP-species-checked": "guaranteed", "IHCP-species-dilution-info": "", "IHCP-species-notes": "", "ICCIF-species-checked": "guaranteed", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "<p></p>", "IHCFr-species-checked": "guaranteed", "IHCFr-species-dilution-info": "", "IHCFr-species-notes": "<p></p>" }, "Rat": { "ICC-species-checked": "predicted", "ICC-species-dilution-info": "", "ICC-species-notes": "", "IP-species-checked": "guaranteed", "IP-species-dilution-info": "", "IP-species-notes": "<p></p>", "FlowCyt-species-checked": "predicted", "FlowCyt-species-dilution-info": "", "FlowCyt-species-notes": "", "WB-species-checked": "guaranteed", "WB-species-dilution-info": "", "WB-species-notes": "<p></p>", "IHCP-species-checked": "predicted", "IHCP-species-dilution-info": "", "IHCP-species-notes": "", "ICCIF-species-checked": "guaranteed", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "<p></p>", "IHCFr-species-checked": "guaranteed", "IHCFr-species-dilution-info": "", "IHCFr-species-notes": "<p></p>" } } }

出荷温度及び保存条件

製品の状態
Liquid
精製方法
Affinity purification Protein G
バッファー組成
pH: 7.2 Preservative: 0.1% Sodium azide Constituents: PBS
出荷温度
Blue Ice
短期保存期間
1-2 weeks
短期保存温度
+4°C
長期保存温度
-20°C
分注に関する情報
Upon delivery aliquot
保管に関する情報
Avoid freeze / thaw cycle

補足情報

This supplementary information is collated from multiple sources and compiled automatically.

HEF1 also known as NEDD9 is an intracellular signaling protein and a member of the Crk-associated substrate family. It has a molecular mass of approximately 93 kDa. The expression of this protein occurs mainly in tissues involved in cell movement and proliferation like lymphoid organs and neural tissues. It is part of the CAS (Crk-associated substrate) proteins hence associated with a wide range of cellular mechanics.
Biological function summary

HEF1 functions as a scaffolding protein involved in various cellular processes including cell adhesion migration and proliferation. It interacts with several other proteins and forms part of complexes such as focal adhesion complexes. It regulates the dynamics of these complexes by modulating signaling pathways linked to cellular adhesion and migration. In neuronal cells it influences axonal and dendritic branching.

Pathways

HEF1 plays a significant role in both the integrin signaling pathway and cell cycle regulation. Through these pathways HEF1 interacts with various key proteins including focal adhesion kinase (FAK) and Src kinase. It positions itself strategically within these pathways and facilitates cross-talk between signaling molecules enabling the coordination of structural and replicative functions in cells.

HEF1 has been implicated in the progression of cancers such as breast cancer and melanoma. Its overexpression often correlates with increased metastatic potential. In breast cancer HEF1 interacts with proteins like Aurora A and BRCA1 linking it to pathways involved in tumor proliferation and invasion. In melanoma alterations in HEF1 levels can affect melanoma cell migration making it a potential target for therapeutic intervention.

製品プロトコール

For this product, it's our understanding that no specific protocols are required. You can visit:

ターゲットの情報

Scaffolding protein which plays a central coordinating role for tyrosine-kinase-based signaling related to cell adhesion (PubMed : 24574519). As a focal adhesion protein, plays a role in embryonic fibroblast migration (By similarity). May play an important role in integrin beta-1 or B cell antigen receptor (BCR) mediated signaling in B- and T-cells. Integrin beta-1 stimulation leads to recruitment of various proteins including CRKL and SHPTP2 to the tyrosine phosphorylated form (PubMed : 9020138). Promotes adhesion and migration of lymphocytes; as a result required for the correct migration of lymphocytes to the spleen and other secondary lymphoid organs (PubMed : 17174122). Plays a role in the organization of T-cell F-actin cortical cytoskeleton and the centralization of T-cell receptor microclusters at the immunological synapse (By similarity). Negatively regulates cilia outgrowth in polarized cysts (By similarity). Modulates cilia disassembly via activation of AURKA-mediated phosphorylation of HDAC6 and subsequent deacetylation of alpha-tubulin (PubMed : 17604723). Positively regulates RANKL-induced osteoclastogenesis (By similarity). Required for the maintenance of hippocampal dendritic spines in the dentate gyrus and CA1 regions, thereby involved in spatial learning and memory (By similarity).
See full target information NEDD9

文献 (35)

Recent publications for all applications. Explore the full list and refine your search

eLife 13: PubMed40698928

2025

Identification of novel human microcephaly-linked protein that mediates cortical progenitor cell division and corticogenesis through .

Applications

Unspecified application

Species

Unspecified reactive species

Aurelie Carabalona,Henna Kallo,Maryanne Gonzalez,Liliia Andriichuk,Ellinoora Elomaa,Florence Molinari,Christiana Fragkou,Pekka Lappalainen,Marja W Wessels,Juha Saarikangas,Claudio Rivera

Neoplasia (New York, N.Y.) 57:101059 PubMed39326322

2024

NEDD9 is transcriptionally regulated by HDAC4 and promotes breast cancer metastasis and macrophage M2 polarization via the FAK/NF-κB signaling pathway.

Applications

Unspecified application

Species

Unspecified reactive species

Wenhong Liu,Guanghua Luo

Signal transduction and targeted therapy 8:11 PubMed36604412

2023

Histone deacetylase inhibitors promote breast cancer metastasis by elevating NEDD9 expression.

Applications

Unspecified application

Species

Unspecified reactive species

Zonglong Hu,Fan Wei,Yi Su,Yafang Wang,Yanyan Shen,Yanfen Fang,Jian Ding,Yi Chen

Journal of gastroenterology and hepatology 37:2255-2263 PubMed36203318

2022

Combined high NEDD9 expression and E-cadherin loss correlate with poor clinical outcome in gastric cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Soyoung Im,Yu Kyung Cho,Donghoon Kang,Ga-Yeong Shin,Eun Sun Jung,Kyo Young Song,Sung Hak Lee,Jae Myung Park

Cancers 14: PubMed35626121

2022

NEDD9 Restrains dsDNA Damage Response during Non-Small Cell Lung Cancer (NSCLC) Progression.

Applications

Unspecified application

Species

Unspecified reactive species

Mariya Tikhomirova,Iuliia Topchu,Aleksandra Mazitova,Vitaly Barmin,Ekaterina Ratner,Alexey Sabirov,Zinaida Abramova,Alexander Y Deneka

BMC cancer 22:533 PubMed35549691

2022

miR-107 is involved in the regulation of NEDD9-mediated invasion and metastasis in breast cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Jiamin Zhou,Xianglin Sun,Xinyu Zhang,Huan Yang,Zhenglin Jiang,Qianqian Luo,Yifei Liu,Guohua Wang

Cancer research 81:3766-3776 PubMed33632899

2021

Susceptibility-Associated Genetic Variation in Contributes to Prostate Cancer Initiation and Progression.

Applications

Unspecified application

Species

Unspecified reactive species

Dong Han,Jude N Owiredu,Bridget M Healy,Muqing Li,Maryam Labaf,Jocelyn S Steinfeld,Susan Patalano,Shuai Gao,Mingyu Liu,Jill A Macoska,Kourosh Zarringhalam,Kellee R Siegfried,Xin Yuan,Timothy R Rebbeck,Changmeng Cai

Frontiers in oncology 10:543591 PubMed33344223

2020

Melatonin Inhibits the Progression of Oral Squamous Cell Carcinoma Inducing miR-25-5p Expression by Directly Targeting NEDD9.

Applications

Unspecified application

Species

Unspecified reactive species

Yanling Wang,Bo Tao,Jiaying Li,Xiaoqun Mao,Wei He,Qinbiao Chen

Clinical epigenetics 11:184 PubMed31801619

2019

ZMYND10, an epigenetically regulated tumor suppressor, exerts tumor-suppressive functions via miR145-5p/NEDD9 axis in breast cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Yan Wang,Liangying Dan,Qianqian Li,Lili Li,Lan Zhong,Bianfei Shao,Fang Yu,Sanxiu He,Shaorong Tian,Jin He,Qian Xiao,Thomas C Putti,Xiaoqian He,Yixiao Feng,Yong Lin,Tingxiu Xiang

Biochemical and biophysical research communications 509:201-208 PubMed30579603

2018

HEF1 regulates differentiation through the Wnt5a/β-catenin signaling pathway in human gastric cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Chun Zhang,Teng Wang,Hao Wu,Lihua Zhang,Kan Li,Fang Wang,Yun Chen,Jian Jin,Dong Hua
View all publications

Abcam product promise

当社は、高品質な試薬を通じてお客様の研究を力強くサポートすることをお約束いたします。ご使用いただく各段階で、常にお客様をサポートできる体制を整えております。万が一、製品が期待通りに機能しない場合は、「Abcam Product Promise」による当社保証制度に基づき、安心してご利用いただけます。
保証に関する詳細については利用規約をご確認ください。

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com